Physitrack PLC (PTRK.ST)
SEK 11.3
(-1.74%)
SEK 11.3
(-1.74%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.57 Million EUR | 330.25% |
| 2022 | 831.66 Thousand EUR | 63385.73% |
| 2021 | 1310.00 EUR | -99.93% |
| 2020 | 1.97 Million EUR | 372.38% |
| 2019 | 417.25 Thousand EUR | 1.62% |
| 2018 | 410.6 Thousand EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | -100.0% |
| 2015 | 12.56 Thousand EUR | -89.66% |
| 2014 | 121.5 Thousand EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.33 Million EUR | 18.79% |
| 2024 Q1 | 3.64 Million EUR | 1.87% |
| 2023 Q3 | 3.78 Million EUR | 2.52% |
| 2023 FY | 3.57 Million EUR | 330.25% |
| 2023 Q1 | 3.01 Million EUR | 262.93% |
| 2023 Q4 | 3.57 Million EUR | -5.52% |
| 2023 Q2 | 3.69 Million EUR | 22.38% |
| 2022 Q3 | 822.63 Thousand EUR | 0.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 FY | 831.66 Thousand EUR | 63385.73% |
| 2022 Q4 | 831.66 Thousand EUR | 1.1% |
| 2022 Q2 | - EUR | 0.0% |
| 2021 Q1 | 1.99 Million EUR | 1.06% |
| 2021 FY | 1310.00 EUR | -99.93% |
| 2021 Q3 | 139.13 Thousand EUR | -93.2% |
| 2021 Q4 | 1310.00 EUR | -99.06% |
| 2021 Q2 | 2.04 Million EUR | 2.71% |
| 2020 Q1 | - EUR | 0.0% |
| 2020 FY | 1.97 Million EUR | 372.38% |
| 2020 Q4 | 1.97 Million EUR | 0.0% |
| 2019 FY | 417.25 Thousand EUR | 1.62% |
| 2018 FY | 410.6 Thousand EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| 2016 FY | - EUR | -100.0% |
| 2015 FY | 12.56 Thousand EUR | -89.66% |
| 2014 FY | 121.5 Thousand EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aino Health AB (publ) | 164 Thousand SEK | -2081.84% |
| Bonzun AB (publ) | 554 Thousand SEK | -545.888% |
| Kontigo Care AB (publ) | 5.95 Million SEK | 39.862% |
| Medhelp Care Aktiebolag (publ) | 5.13 Million SEK | 30.263% |
| RaySearch Laboratories AB (publ) | 529.35 Million SEK | 99.324% |
| Surgical Science Sweden AB (publ) | 53.26 Million SEK | 93.282% |